Bipolar Disorder Clinical Trials

Showing 221-240 of 340 trials

Bipolar Disorder Study for Men and Women

NCT00056277

A Placebo Controlled Study Evaluating Efficacy and Safety of Medication in Patients with Bipolar Disorder

GlaxoSmithKline150 participantsStarted Feb 2003

Beverly Hills, California, United States • La Jolla, California, United States • San Diego, California, United States +17 more locations

COMPLETEDPHASE3

A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -

NCT00566020

This study is planned to assess the long-term safety of lamotrigine in Japanese patients with bipolar I disorder who will continue into the 52-week extension upon completion of a double-blind comparative study (Study No.: SCA104779 (NCT00550407)), i.e. the patients who receive the addition of any additional treatment to intervene in a mood episode in the double-blind phase or the patients completing the double-blind phase.

Bipolar Disorder

GlaxoSmithKline92 participantsStarted May 2008

Aichi, Japan • Chiba, Japan • Chiba, Japan +49 more locations

Bipolar Disorder Study for Men and Women

A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -

Related Searches

The Immune System and Psychiatric Disorders

An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder.

An fMRI Study on Temporal Discounting in Bipolar Disorder

Minocycline for Bipolar Depression

Zonisamide for Heavy Drinkers With Bipolar Disorder

Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression

Cognitive Remediation on Patients With Bipolar Disorder and Memory Complaints

NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression

Transcranial Direct Current Stimulation for the Treatment of Bipolar Depression

Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine

Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder

Depression And Bipolar Disorder

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Bipolar Study in Adults at Least 18 Years of Age

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

Lifestyle Intervention for Diabetes and Weight Management in Psychosis